Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H M Wexler

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
Antimicrobial Agents and Chemotherapy|July 18, 2000
In vitro activities of MK-826 (L-749,345) against 363 strains of anaerobic bacteriaH M Wexler, D Molitoris, S M Finegold
Clinical Therapeutics|January 1, 1988
Antibiotic susceptibility testing of anaerobic organisms using the agar dilution method: comparison of three techniquesH M Wexler, D Reeves, S M Finegold
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 6, 1997
Sources and antimicrobial susceptibilities of Campylobacter gracilis and Sutterella wadsworthensisE Molitoris, H M Wexler, S M Finegold
Scandinavian Journal of Urology and Nephrology. Supplementum|January 1, 1984
Biochemical and polyacrylamide gel electrophoretic analyses of vaginosis-associated anaerobic curved rodsE J Baron, H M Wexler, S M Finegold
The Journal of Antimicrobial Chemotherapy|March 27, 2001
In vitro activity of telithromycin (HMR 3647) against 502 strains of anaerobic bacteriaH M Wexler, E Molitoris, D Molitoris, et al.
The Journal of Antimicrobial Chemotherapy|October 1, 1994
In-vitro activity of clinafloxacin (CI-960) and PD 131628-2 against anaerobic bacteriaH M Wexler, E Molitoris, D Reeves, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1994
In vitro activity of DU-6859a against anaerobic bacteriaH M Wexler, E Molitoris, D Reeves, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1996
In vitro activities of trovafloxacin against 557 strains of anaerobic bacteriaH M Wexler, E Molitoris, D Molitoris, et al.
Infectious Disease Clinics of North America|June 1, 1993
Current perspectives on anaerobic infections: diagnostic approachesS M Finegold, H R Jousimies-Somer, H M Wexler
The Journal of Antimicrobial Chemotherapy|December 1, 1991
In-vitro activity of temafloxacin against anaerobic bacteria: a comparative studyS M Finegold, E Molitoris, D Reeves, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Antimicrobial Agents and Chemotherapy|July 18, 2000
In vitro activities of MK-826 (L-749,345) against 363 strains of anaerobic bacteriaH M Wexler, D Molitoris, S M Finegold
Clinical Therapeutics|January 1, 1988
Antibiotic susceptibility testing of anaerobic organisms using the agar dilution method: comparison of three techniquesH M Wexler, D Reeves, S M Finegold
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 6, 1997
Sources and antimicrobial susceptibilities of Campylobacter gracilis and Sutterella wadsworthensisE Molitoris, H M Wexler, S M Finegold
Scandinavian Journal of Urology and Nephrology. Supplementum|January 1, 1984
Biochemical and polyacrylamide gel electrophoretic analyses of vaginosis-associated anaerobic curved rodsE J Baron, H M Wexler, S M Finegold
The Journal of Antimicrobial Chemotherapy|March 27, 2001
In vitro activity of telithromycin (HMR 3647) against 502 strains of anaerobic bacteriaH M Wexler, E Molitoris, D Molitoris, et al.
The Journal of Antimicrobial Chemotherapy|October 1, 1994
In-vitro activity of clinafloxacin (CI-960) and PD 131628-2 against anaerobic bacteriaH M Wexler, E Molitoris, D Reeves, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1994
In vitro activity of DU-6859a against anaerobic bacteriaH M Wexler, E Molitoris, D Reeves, et al.
Antimicrobial Agents and Chemotherapy|September 1, 1996
In vitro activities of trovafloxacin against 557 strains of anaerobic bacteriaH M Wexler, E Molitoris, D Molitoris, et al.
Infectious Disease Clinics of North America|June 1, 1993
Current perspectives on anaerobic infections: diagnostic approachesS M Finegold, H R Jousimies-Somer, H M Wexler
The Journal of Antimicrobial Chemotherapy|December 1, 1991
In-vitro activity of temafloxacin against anaerobic bacteria: a comparative studyS M Finegold, E Molitoris, D Reeves, et al.
Pageof 7